Author:
Michael E.Nelson
Timothy B.Erickson
Description
- Amanitin/phalloidin:
- Species:
- Amanita phalloides (death cap)
- Amanita virosa/Amanita verna (destroying angel)
- Galerina marginata, Galerina venenata
- Mechanism:
- Cyclopeptide toxins inhibit RNA polymerase 2, which kills GI epithelium, hepatocytes, nephrocytes
- Gyromitrin:
- Species:
- Gyromitra esculenta (false morels)
- Other Gyromitra spp.
- Mechanism:
- Gyromitrin hydrolyzed to monomethylhydrazine
- Inhibits pyridoxal phosphate
- Results in decreased GABA production
- Damage to RBCs, hepatocytes, neurons
- Muscarine:
- Species:
- Inocybe (several species)
- Clitocybe (several species)
- Boletus sp.
- Rubinoboletus sp.
- Mechanism:
- Muscarine acts like acetylcholine resulting in parasympathomimetic symptoms
- Coprine:
- Species:
- Coprinus atramentarius (inky caps)
- Mechanism:
- Blocks acetaldehyde dehydrogenase
- Causes disulfiram-like reaction if mixed with alcohol
- Ibotenic acid/muscimol:
- Species:
- Amanita pantherina (panther cap)
- Amanita muscaria (fly agaric)
- Amanita ibotengutake (Japanese Ringed-Bulb)
- Mechanism:
- Ibotenic acid is derivative of glutamate
- Muscimol is GABA derivative
- Psilocin/psilocybin:
- Species:
- Psilocybe and Panaeolus spp. as well as others
- Stalks may turn blue upon hand ling, nonspecific
- Mechanism:
- Similar structure to lysergic acid diethylamide, effect serotonin receptor
- Gastric irritants:
- Many various mushrooms, including those normally considered edible
- Orellanine:
- Species:
- Cortinarius (several species)
- Mechanism:
- Neurovascular toxins
- Species:
- Clitocybe amoenolens (Poison Dwarf Bamboo mushroom)
- Clitocybe acromelalgia
- Mechanism:
- Acromelic acids A-E, Kainate analogs, peripheral glutamate receptors
- Myotoxin
- Species:
- Tricholoma equestre (Yellow Knight, man on horse)
- Mechanism unknown, induces rhabdomyolysis
Signs and Symptoms
- Amanitin/phalloidin:
- Nausea
- Vomiting
- Abdominal cramps
- Bloody diarrhea
- Clinical course:
- Onset of symptoms delayed 6-36 hr with development of GI symptoms
- Transient latent phase may last 2 d (no pain/symptoms)
- Can progress to hepatic or renal failure and death in 2-6 d
- Most lethal mushroom toxins
- Gyromitrin:
- 1st 5-10 hr:
- Abdominal cramps
- Nausea/vomiting
- Watery diarrhea
- Later symptoms:
- Weakness
- Cyanosis
- Confusion
- Seizures
- Coma
- Muscarine:
- Cholinergic symptoms include:
- Miosis
- Salivation
- Lacrimation
- Sweating
- Diarrhea
- Flushed skin
- Nausea
- Bradycardia
- Bronchoconstriction
- Onset usually within 1 hr (may be delayed)
- Coprine:
- Disulfiram-like reaction within minutes to hours when combined with alcohol:
- Flushing
- Sweating
- Nausea/vomiting
- Palpitations
- Ibotenic acid/muscimol:
- Relatively rapid onset of 30-120 min
- GABA agonist effects include:
- Hallucinations
- Dysarthria
- Ataxia
- Somnolence/coma
- Glutamatergic effects (mainly pediatrics):
- Seizures
- Hyperkinetic behavior
- Muscle cramps/myoclonic movements
- Psilocin/psilocybin:
- Rapid onset, usually resolves in 6-12 hr
- Visual hallucinations
- Alteration of perception
- Mydriasis
- Tachycardia
- Fever and seizures in children
- Gastric irritants:
- Group of toxins that cause nausea, vomiting, intestinal cramps, and watery diarrhea
- Onset 30 min-3 hr, usually resolved in 6-12 hr
- Orellanine/Amanita smithiana:
- Nausea/vomiting
- Headache
- Sweating
- Chills
- Low-back pain
- Polydipsia
- Clinical course:
- Neurovascular toxin
- Erythromelalgia: Erythema, swelling, pain of distal extremities
- Clinical course:
- Onset of symptoms 24 hr after ingestion
- Paresthesia of digits, burning pain
- Red/swollen hand s and feet
- Heat and dependent position worsen pain
- Can last weeks to months
- Electromyogram: Polyneuropathy with sensory and motor fiber impairment
- Myotoxin/T. equestre:
- Acute rhabdomyolysis:
- Myalgias/arthralgias
- Hematuria/dark urine
- Decreased urine output
- Dehydration
- Myocarditis, arrhythmias
History
- Time of ingestion
- Time of symptom onset
- Quantity ingested
- Preparation: Raw or cooked
- Picked in the wild or store-bought
- Coingestants, other mushrooms
- Alcohol/drug use history
- Symptoms of family members, friends
Physical Exam
- Vital signs
- Changes in mental status
- Pupillary response
- Cardiopulmonary exam
- Abdominal exam
- Neurologic exam
Essential Workup
- Mushroom description:
- Pileus (cap); margin shape
- Stipe (stem)
- Lamellae (gills)
- Veil
- Annulus (ring)
- Volva
- Store mushroom in brown paper bag for future identification:
- <3% of cases result in an exact mushroom identification
- Digital photography and electronic image transfer to poison-control center or regional mycologist
Diagnostic Tests & Interpretation
Lab
- CBC
- Prothrombin time (PT), partial thromboplastin time (PTT)
- Electrolytes, BUN, creatinine, glucose
- Urinalysis
- LFTs, creatine phosphokinase (CPK)
- Imaging
- Spore print: Mycologist needed for specific genus/species interpretation
Differential Diagnosis
- Very broad differential
- Gastroenteritis, viral vs. bacterial
- Hepatitis/acetaminophenhepatotoxicity
- Acute renal failure (many causes)
- Rhabdomyolysis (many causes)
- Cholinergic syndrome (e.g., organophosphates)
- Anticholinergic syndrome
- Seizures (many causes)
- Vasculitis
Prehospital
Bring any unconsumed mushrooms or mushroom pieces to hospital to aid in diagnosis:
- Refrigerate specimens if possible, place in brown paper bag
Initial Stabilization/Therapy
ED Treatment/Procedures
General Measures
- Decontamination:
- Activated charcoal (50-100 g)
- Gastric decontamination if early after ingestion and patient:
- Has not yet vomited
- Has normal mental and respiratory status
- Is not undergoing hallucinations
- Fluid rehydration and electrolyte replacement as necessary
- Call local poison-control center at 800-222-1222 and request mycologist - digital picture may be electronically sent for identification
- Obtain specimens (vomitus if needed) for identification
Mushroom-Specific Therapy
- Amanitin/phalloidin:
- Administer activated charcoal PO q2-4h
- Hypoglycemia and elevated PT:
- Signs of liver failure
- Administer fresh-frozen plasma and vitamin K for coagulation disorders with active bleeding
- Administer calcium in presence of hypocalcemia
- Liver transplant for severe hepatic necrosis
- Consider N-acetylcysteine, high-dose penicillin G, or silibinin or polymyxin B if available (thioctic acid controversial)
- Gyromitrin:
- Treat seizure with benzodiazepines, barbiturates, or propofol.
- Treat liver dysfunctions similar to amanitin/phalloidin group
- Dialysis for renal failure
- Muscarine:
- Coprine:
- Self-limited toxicity - supportive care
- Avoid syrup of ipecac (contains alcohol)
- β-Blockers for cardiac dysrhythmias
- Ibotenic acid/muscimol:
- Usually self-limited toxicity
- Provide supportive care
- Monitor for hypotension
- Treat moderate symptoms with benzodiazepines, if severe anticholinergic symptoms; consider physostigmine
- Psilocin/psilocybin:
- Self-limited toxicity
- Dark, quiet room and reassurance
- Benzodiazepines for agitation
- External cooling measures if needed in children
- GI Irritants:
- When poisoning from above groups not suspected, administer fluids and antiemetics
- Provide supportive care
- Orellanine and A. smithiana:
- Closely monitor BUN, creatinine, electrolytes, and urine output
- Forced diuresis with furosemide contraindicated
- Diuresis with alkalinization of urine with NaHCO3 if signs of rhabdomyolysis
- Hemodialysis/renal transplantation may be needed
- Neurovascular/Erythromelalgia:
- Place extremities affected in cold water
- Analgesics and supportive care
- Consider nicotinic acid (controversial)
- Myotoxin/T. equestre:
- Fluid hydration
- Check and follow CPK
- Monitor urine output
Medication
- Activated charcoal slurry: 1-2 g/kg up to 100 g PO
- Atropine: 0.5 mg (peds: 0.02 mg/kg) IV; repeat 0.5-1 mg IV (peds: 0.04 mg/kg) q10min if secretions recur, to max. 1 mg/kg in children and 2 mg/kg in adults
- Dextrose: D50W 1 amp: 50 mL or 25 g (peds: D25W 2-4 mL/kg) IV
- Diazepam (benzodiazepine): 5-10 mg (peds: 0.2-0.5 mg/kg) IV
- Lorazepam (benzodiazepine): 2-6 mg (peds: 0.03-0.05 mg/kg) IV
- N-acetylcysteine: 150 mg/kg over 1 hr, then 12.5 mg/kg/hr for 4 hr then 6.25 mg/kg until hepatic injury resolves
- Naloxone (Narcan): 0.04-2 mg (peds: 0.1 mg/kg) IV or IM initial dose
- Nicotinic acid: 20-100 mg/day × 7 days, dose given over 1 hr IV; 100 mg/d orally over 3 mo with gradual taper
- Physostigmine: 0.5-2 mg IM or IV in adults
- Polymyxin B: 1.5-2.5 mg/kg/d in 2 doses administered as 1-hr IV infusions
- Propranolol: 1 mg (peds: 0.01-0.1 mg/kg) IV
- Pyridoxine: 70 mg/kg up to 5 g IV over 30 min
- Silibinin: 5 mg/kg IV over 1 hr then 20 mg/kg/24 hr for 3 d
- Thiamine (vitamin B1): 100 mg (peds: 50 mg) IV or IM
Disposition
Admission Criteria
- All symptomatic patients:
- Protracted vomiting, dehydration, liver or renal toxicity, or seizures
- Transfer to tertiary medical center for early signs of renal or hepatic failure
- Symptomatic infants and young children found with mushrooms:
- ICU admission for known ingestion of an amanitin-containing mushroom:
- Early liver service consultation
Discharge Criteria
Asymptomatic during 6-8 hr with 24 hr of close home observation and close follow-up (if reliable caregivers)
Issues for Referral
Potential liver or renal transplantation
Follow-up Recommendations
Drug detoxification programs if chronic recreational use
ICD9
988.1 Toxic effect of mushrooms eaten as food
ICD10
T62.0X1A Toxic effect of ingested mushrooms, accidental, init
SNOMED
86505009 Toxic effect from eating mushrooms (disorder)
216771005 Accidental poisoning from mushrooms (disorder)
242358002 Accidental ingestion of hallucinogenic mushrooms (disorder)